Abeona Therapeutics

$Abeona Therapeutics(ABEO)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001641172-25-023715  Act: 34  Size: 330 KB 网页链接

$Abeona Therapeutics(ABEO)$ 144 Report of proposed sale of securities Accession Number: 0001972481-25-000148  Act: 33  Size: 5 KB 网页链接

$Abeona Therapeutics(ABEO)$ SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0002052113-25-002982  Act: 34  Size: 10 KB 网页链接

$Abeona Therapeutics(ABEO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-25-016544  Size: 5 KB 网页链接

$Abeona Therapeutics(ABEO)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001641172-25-023716  Act: 34  Size: 7 MB 网页链接

$Abeona Therapeutics(ABEO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-25-014527  Size: 5 KB 网页链接

$Abeona Therapeutics(ABEO)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0001104659-25-097132  Act: 34  Size: 11 KB 网页链接

$Abeona Therapeutics(ABEO)$ Nantahala Capital Partners Limited Partnership 于 2025 年 10 月 6 日 向美国证券交易委员会（SEC）提交了一份 Schedule 13G，披露其对 Abeona Therapeutics Inc. 的实益持股情况。
截至 2025 年 9 月 29 日，Nantahala 被视为实益持有 2,618,462 股 Abeona Th...

$Abeona Therapeutics(ABEO)$ SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0002089521-25-000001  Act: 34  Size: 205 KB 网页链接

$Abeona Therapeutics(ABEO)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0000919574-25-004720  Act: 34  Size: 17 KB 网页链接

$Abeona Therapeutics(ABEO)$ 144 Report of proposed sale of securities Accession Number: 0001972481-25-000173  Act: 33  Size: 6 KB 网页链接

$Abeona Therapeutics(ABEO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001641172-25-020575  Size: 5 KB 网页链接

$Abeona Therapeutics(ABEO)$ 144 Report of proposed sale of securities Accession Number: 0001972481-25-000216  Act: 33  Size: 5 KB 网页链接

$Abeona Therapeutics(ABEO)$ 144 Report of proposed sale of securities Accession Number: 0001972481-25-000219  Act: 33  Size: 5 KB 网页链接

$Abeona Therapeutics(ABEO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001641172-25-024384  Size: 5 KB 网页链接

$Abeona Therapeutics(ABEO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-25-016542  Size: 5 KB 网页链接

$Abeona Therapeutics(ABEO)$ 8-K Current report, items 1.01, 2.03, and 9.01 Accession Number: 0001641172-25-020227  Act: 34  Size: 584 KB 网页链接

$Abeona Therapeutics(ABEO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-25-012099  Size: 5 KB 网页链接

$Abeona Therapeutics(ABEO)$ 144 Report of proposed sale of securities Accession Number: 0001972481-25-000218  Act: 33  Size: 6 KB 网页链接

$Abeona Therapeutics(ABEO)$ 144 Report of proposed sale of securities Accession Number: 0001972481-25-000220  Act: 33  Size: 5 KB 网页链接